摘要
目的分析比较鼻咽癌放疗后复发行再程放疗的疗效。方法选取本院经放疗后复发行再程放疗的鼻咽癌患者80例为研究对象,回顾性分析其复发后行再程放疗的效果、并发症、3年生存率及5年生存率。结果患者接受再程调强放疗后总有效率为72.5%;所有患者癌细胞均得到控制,未发生严重并发症,对症治疗后症状缓解;持续5年随访,3年生存率为71.25%,5年生存率为21.25%,死亡率为41.25%。结论 1放疗后复发的鼻咽癌患者行再程放疗后,临床疗效显著,并发症少,提高患者的生存率;2患者复发时间越早,再程放疗疗效越显著,鼻咽癌肿瘤靶区的划分和化疗是预后的关键因素。
Objective To study the efficacy of reirradiation therapy after relapse of patients subject to nasopharyngeal carcinoma radiotherapy, and to conduct analysis and comparison. Method Eighty patients subject to re-irradiation radiotherapy therapy after relapse of nasopharyngeal carcinoma radiotherapy in the inpatient department of this hospital, and the efficacy, complications, 3-year survival rate and the 5-year survival rate of re-irradiation radiotherapy therapy were retrospectively analyzed. Result The total effective rate of patients subject to re-irradiation radiotherapy therapy was 72.5%, cancer cells of all patients were controlled, no serious complications occurred, and symptoms were relieved upon symptomatic treatment. The 3-year survival rate of patients was 71.25%after continual follow-ups of 5 years, and the 3-year survival rate of patients was 21.25%. The 5-year mortality was 41.25%after follow-ups. Conclusion ①Clinical efifcacy of re-irradiation radiotherapy therapy on patients subject to nasopharyngeal carcinoma is signiifcant, a few complications are found, and the survival rate of patients can be improved.②The therapy efifcacy of reirradiation therapy on patients was more signiifcant than the earlier relapse time of patients, and the division and chemotherapy for nasopharyngeal tumor target are key factors of prognosis factor.
出处
《中国医学前沿杂志（电子版）》
2014年第9期42-44,共3页
Chinese Journal of the Frontiers of Medical Science(Electronic Version)
关键词
鼻咽癌
放疗
复发
再程放疗
疗效分析
Nasopharyngeal carcinoma
Radiation therapy
Relapse
Re-irradiation radiotherapy
Efifcacy analysis
